Patents

Biopharma company issued patent for PCA technology

Published in Biotech Business Week, January 3rd, 2005

Odyssey Thera, Inc., announced the issuance of U.S. Patent No. 6,828,099 entitled "Protein-fragment complementation assays (PCA) for the detection of protein-protein, protein-small molecule and protein-nucleic acid interactions based on the E. Coli TEM- 1 beta-lactamase."

PCA involves the engineering of probes of molecular interactions, with widespread applications for drug discovery and pharmacological profiling in living cells. Professor Stephen W. Michnick, of the University of Montreal, invented PCA and has applied the technology to a wide range of reporters for high-throughput and high-content applications. PCA is applicable to any and all drug targets, drug...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-01-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry